Aptamers as Versatile Molecular Tools for Antibody Production Monitoring and Quality Control
- 9 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (28) , 12079-12086
Abstract
Antibody drugs have been used to treat many diseases, and to date, this has been the most rapidly growing drug class. However, the lack of suitable methods for real-time and high-throughput monitoring of antibody production and quality control has been a hindrance to the further advancement of antibody drugs or biosimilars. Therefore, we herein report a versatile tool for one-step fluorescence monitoring of antibody production by using aptamer probes selected through the in vitro SELEX method. In this case, DNA aptamers were selected against the humanized IgG1 antibody drug trastuzumab with high specificity and affinity with a Kd value of aptamer CH1S-3 of 10.3 nM. More importantly, the obtained aptamers were able to distinguish native from heat-treated, whereas antibodies failed this test. On the basis of the advantages of rapid detection for aptamers, we designed aptamer molecular beacons for direct and sensitive detection of trastuzumab in complex samples. Unlike traditional antibody-based ELISA, the signal was observed directly upon interaction with the target without the need for time-consuming binding and multiple washing steps. To further highlight biomedical applications, the use of aptamers as potential tools for quality control and traceless purification of antibody drugs was also demonstrated. Thus, aptamers are shown to be promising alternatives for antibody production monitoring, quality control, and purification, providing technical support to accelerate antibody drug development.Keywords
Funding Information
- Natural Science Foundation of Fujian Province (2017J06004)
- Science and Technology Commission of Shanghai Municipality (19QA1405400)
- National Natural Science Foundation of China (21622502)
This publication has 40 references indexed in Scilit:
- CHO Quasispecies—Implications for Manufacturing ProcessesProcesses, 2013
- TrastuzumabThe Oncologist, 2011
- Fragmentation of monoclonal antibodiesmAbs, 2011
- Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alterationProceedings of the National Academy of Sciences, 2011
- Antibody Detection by Using a FRET‐Based Protein Conformational SwitchChemBioChem, 2010
- Cell culture processes for monoclonal antibody productionmAbs, 2010
- Development of an Aptamer Beacon for Detection of Interferon-GammaAnalytical Chemistry, 2010
- Molecular Beacons for DNA Binding Proteins: An Emerging Technology for Detection of DNA Binding Proteins and Their LigandsASSAY and Drug Development Technologies, 2006
- Design, synthesis, and application of a Protein A mimeticNature Biotechnology, 1998
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990